Click Here to return To Results

 

Long-term Donepezil Treatment in 565 Patients with Alzheimer's Disease (AD2000): Randomised Double-Blind Trial Lancet 363:2105-2115,2100, AD2000 Collaborative Group, 2004 See this aricle in Pubmed Article Abstract Donepezil is not cost effective, with benefits below minimally relevant thresholds. More effective treatments than cholinesterase inhibitors are needed for AlzheimerÆs disease.

Related Tags

(click to filter results - removes previous filter) Alzheimer's disease Alzheimer's disease,treatment of anticholinesterase conflict of interest controversies in neurology cost effectiveness dementia donepezil Mini Mental Status Examination treatment of neurologic disorder

Click Here to return To Results